Shane Storey
Stock Analyst at Canaccord Genuity
(2.93)
# 2,777
Out of 4,792 analysts
348
Total ratings
46.2%
Success rate
2.1%
Average return
Main Sectors:
Stocks Rated by Shane Storey
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ASX: CSL CSL Limited | Reiterated: Hold | $106.31 → $185.00 | $169.50 | +9.14% | 29 | Sep 4, 2026 | |
| ASX: ACW Actinogen Medical Limited | Reiterated: Buy | $0.08 | $0.06 | +37.93% | 6 | Sep 3, 2026 | |
| ASX: SOM SomnoMed Limited | Reiterated: Buy | $1.00 → $0.76 | $0.34 | +126.87% | 23 | Aug 31, 2026 | |
| ASX: PNV PolyNovo Limited | Downgraded: Hold | $1.58 → $0.95 | $1.00 | -5.00% | 17 | Aug 27, 2026 | |
| ASX: TLX Telix Pharmaceuticals Limited | Reiterated: Buy | $30.00 → $28.25 | $16.76 | +68.56% | 56 | Aug 20, 2026 | |
| ASX: RMD ResMed Inc. | Reiterated: Buy | $44.50 → $40.00 | $30.30 | +32.01% | 21 | Jul 21, 2026 | |
| NZE: FPH Fisher & Paykel Healthcare Corporation Limited | Reiterated: Buy | $46.29 → $45.05 | $43.95 | +2.51% | 16 | May 27, 2026 | |
| ASX: ARX Aroa Biosurgery Limited | Reiterated: Buy | $1.16 → $1.35 | $0.54 | +152.34% | 28 | May 3, 2026 | |
| ASX: COH Cochlear Limited | Reiterated: Buy | $295.00 → $120.00 | $137.58 | -12.78% | 19 | Apr 29, 2026 | |
| ASX: MVF Monash IVF Group Limited | Reiterated: Hold | $0.69 → $0.86 | $0.81 | +6.17% | 20 | Apr 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $1.33 → $1.26 | $0.73 | +73.79% | 2 | Apr 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $3.00 → $2.57 | $2.29 | +12.23% | 12 | Mar 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5.43 → $5.55 | $2.75 | +101.82% | 21 | Mar 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $3.85 → $2.40 | $2.76 | -13.04% | 3 | Feb 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $0.07 → $0.06 | $0.01 | +1,100.00% | 22 | Feb 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $350.00 | $166.87 | +109.74% | 5 | Nov 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $0.85 → $0.80 | $0.26 | +207.69% | 4 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $37.00 | $53.70 | -31.10% | 11 | Oct 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $32.84 | $8.01 | +309.99% | 3 | Sep 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $3.00 → $2.81 | $0.28 | n/a | 4 | Sep 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $1.20 | $0.04 | n/a | 2 | Sep 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $3.00 | $2.32 | n/a | 3 | Sep 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $26.50 | $20.21 | n/a | 1 | Aug 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8.50 | $2.24 | n/a | 7 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $1.00 | $0.01 | n/a | 2 | Mar 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $5.95 → $7.40 | $3.00 | n/a | 2 | Feb 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $0.71 → $0.55 | $0.40 | n/a | 3 | Feb 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $0.17 → $0.06 | $1.00 | n/a | 2 | Sep 2, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $0.50 → $0.55 | $0.10 | n/a | 3 | Aug 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $0.75 | $0.01 | n/a | 1 | Jun 1, 2022 |
CSL Limited
Sep 4, 2026
Reiterated: Hold
Price Target: $106.31 → $185.00
Current: $169.50
Upside: +9.14%
Actinogen Medical Limited
Sep 3, 2026
Reiterated: Buy
Price Target: $0.08
Current: $0.06
Upside: +37.93%
SomnoMed Limited
Aug 31, 2026
Reiterated: Buy
Price Target: $1.00 → $0.76
Current: $0.34
Upside: +126.87%
PolyNovo Limited
Aug 27, 2026
Downgraded: Hold
Price Target: $1.58 → $0.95
Current: $1.00
Upside: -5.00%
Telix Pharmaceuticals Limited
Aug 20, 2026
Reiterated: Buy
Price Target: $30.00 → $28.25
Current: $16.76
Upside: +68.56%
ResMed Inc.
Jul 21, 2026
Reiterated: Buy
Price Target: $44.50 → $40.00
Current: $30.30
Upside: +32.01%
Fisher & Paykel Healthcare Corporation Limited
May 27, 2026
Reiterated: Buy
Price Target: $46.29 → $45.05
Current: $43.95
Upside: +2.51%
Aroa Biosurgery Limited
May 3, 2026
Reiterated: Buy
Price Target: $1.16 → $1.35
Current: $0.54
Upside: +152.34%
Cochlear Limited
Apr 29, 2026
Reiterated: Buy
Price Target: $295.00 → $120.00
Current: $137.58
Upside: -12.78%
Monash IVF Group Limited
Apr 29, 2026
Reiterated: Hold
Price Target: $0.69 → $0.86
Current: $0.81
Upside: +6.17%
Apr 20, 2026
Reiterated: Buy
Price Target: $1.33 → $1.26
Current: $0.73
Upside: +73.79%
Mar 4, 2026
Reiterated: Buy
Price Target: $3.00 → $2.57
Current: $2.29
Upside: +12.23%
Mar 4, 2026
Reiterated: Buy
Price Target: $5.43 → $5.55
Current: $2.75
Upside: +101.82%
Feb 17, 2026
Downgraded: Hold
Price Target: $3.85 → $2.40
Current: $2.76
Upside: -13.04%
Feb 2, 2026
Reiterated: Buy
Price Target: $0.07 → $0.06
Current: $0.01
Upside: +1,100.00%
Nov 18, 2025
Reiterated: Buy
Price Target: $350.00
Current: $166.87
Upside: +109.74%
Nov 7, 2025
Reiterated: Buy
Price Target: $0.85 → $0.80
Current: $0.26
Upside: +207.69%
Oct 3, 2025
Reiterated: Hold
Price Target: $37.00
Current: $53.70
Upside: -31.10%
Sep 24, 2025
Reiterated: Buy
Price Target: $32.84
Current: $8.01
Upside: +309.99%
Sep 11, 2025
Reiterated: Buy
Price Target: $3.00 → $2.81
Current: $0.28
Upside: n/a
Sep 10, 2025
Reiterated: Buy
Price Target: $1.20
Current: $0.04
Upside: n/a
Sep 2, 2025
Reiterated: Buy
Price Target: $3.00
Current: $2.32
Upside: n/a
Aug 28, 2025
Reiterated: Buy
Price Target: $26.50
Current: $20.21
Upside: n/a
Aug 8, 2025
Reiterated: Buy
Price Target: $8.50
Current: $2.24
Upside: n/a
Mar 24, 2025
Reiterated: Hold
Price Target: $1.00
Current: $0.01
Upside: n/a
Feb 27, 2025
Downgraded: Hold
Price Target: $5.95 → $7.40
Current: $3.00
Upside: n/a
Feb 21, 2023
Reiterated: Hold
Price Target: $0.71 → $0.55
Current: $0.40
Upside: n/a
Sep 2, 2022
Downgraded: Hold
Price Target: $0.17 → $0.06
Current: $1.00
Upside: n/a
Aug 29, 2022
Reiterated: Hold
Price Target: $0.50 → $0.55
Current: $0.10
Upside: n/a
Jun 1, 2022
Reiterated: Buy
Price Target: $0.75
Current: $0.01
Upside: n/a